Captopril vs Nivolumab

Captopril vs Nivolumab: Overview

This comparison examines the pharmacological differences between Captopril and Nivolumab.

Mechanism of Action

Captopril: First orally active ACE inhibitor; contains thiol group that binds zinc at ACE active site.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Captopril — 1.9 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Captopril — C9H15NO3S.

Molecular Weight: Captopril — 217.2850 g/mol.

Type: Captopril — Small molecule; Nivolumab — Antibody.